Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Extended infusion of beta-lactam and carbapenem antibiotics: pharmacokinetics in ICU patients with varying renal function
2008-006825-15Phase 3Completed
- Sponsor
- Ghent University Hospital
- Start
- Jan 2009
- Modality
- Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of piperacillin + tazobactam, meropenem, piperacillin and tazobactam in Infection (3 arms), sponsored by Ghent University Hospital. Primary endpoint: Renal clearance of beta-lactam and carbapenem antibiotics. Started Jan 2009; status: completed.
02
Drugs
03
Conditions
Infection
Beyond the preview
Go deeper on 2008-006825-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006825-15.